logo BDSP

Base documentaire

  1. Potential for cost economies in guiding therapy in patients with metastatic breast cancer.

    Article - En anglais

    Therapeutic response in patients with advanced breast cancer is conventionally assessed with reference to criteria devised by the International Union Against Cancer.

    Evidence to date suggests, however, that assessments of equivalent quality may be obtained at lower cost from the use of serum markers.

    The paper presents estimates of potential cost savings resulting from the use of serum markers in place of conventional assessment and argues that the size of these savings merits the establishment of a randomised controlled trial.

    Mots-clés Pascal : Tumeur maligne, Glande mammaire, Stade avancé, Marqueur tumoral, Efficacité traitement, Chimiothérapie, Traitement, Anticancéreux, Analyse coût efficacité, Economie santé, Sérum, Homme, Glande mammaire pathologie

    Mots-clés Pascal anglais : Malignant tumor, Mammary gland, Advanced stage, Tumoral marker, Treatment efficiency, Chemotherapy, Treatment, Antineoplastic agent, Cost efficiency analysis, Health economy, Serum, Human, Mammary gland diseases

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 95-0428117

    Code Inist : 002B02R01. Création : 01/03/1996.